Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality

Journal of Pathology

Volumn 185, Issue 2, 1998, Pages 130-138

  Al Mulla, Fahd ^a   Going, James J ^b   Sowden, Evin T H H ^a   Winter, Alison ^b   Pickford, Ian R ^c   Birnie, George D ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Colorectal cancer; Disease aggression; Ki ras; Metastasis; Mutation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MUTATION RATE; ONCOGENE RAS; POINT MUTATION; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; GENES, RAS; GENETIC HETEROGENEITY; GLYCINE; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; POINT MUTATION; POLYMERASE CHAIN REACTION; SURVIVAL RATE; VALINE;

EID: 0031840930     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199806)185:2<130::AID-PATH85>3.0.CO;2-M     Document Type: Article

References (41)

1. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in Cancer Incidence and Mortality. IARC Scientific Publication No. 121. Lyon: IARC, 1993: 225-256.
2. Burke D, Allen-Mersh TG. Colorectal liver metastases. Postgrad Med J 1996; 72: 464-469.
3. Dukes C. The classification of cancer of the rectum. J Pathol Bacteriol 1932; 35: 323-332.
4. Vogelstein B, Fearon E, Hamilton S, et al. Genetic alterations during colorectal-tumour development. N Engl J Med 1988; 319: 525-531.
5. Shibata D, Schaeffer J, Li ZH, Capella G, Perucho M. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. J Natl Cancer Inst 1993; 85: 1058-1063.
6. Li ZH, Zheng J, Weiss LM, Shibata D. c-K-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol 1994; 144: 303-309.
7. Giaretti W, Monaco R, Pujic N, Rapallo A, Nigro S, Geido E. Intratumour heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy. Am J Pathol 1996; 149: 237-245.
8. Konishi N, Hiasa Y, Matsuda H, et al. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumour suppressor gene in human prostatic cancer. Am J Pathol 1995; 147: 1112-1122.
9. Van Elsas A, Zerp S, van der Flier S, et al. Analysis of N-ras mutations in human cutaneous melanoma: tumour heterogeneity detected by polymerase chain reaction/single strand conformation polymorphism analysis. Recent Results Cancer Res 1995; 139: 57-67.
10. Ohnishi T, Tomita N, Monden T, et al. A detailed analysis of the role of K-ras gene mutation in the progression of colorectal adenoma. Br J Cancer 1997; 75: 341-347.
11. Novelli MR, Williamson JA, Tomlinson IPM, et al. Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science 1996; 272: 1187-1190.
12. Chambers AF, Tuck AB. Ras-responsive genes and tumour metastasis. Crit Rev Oncogenesis 1993; 4: 95-114.
13. Moerkerk P, Arends JW, van Driel M, de Bruine A, de Goeij A, ten Kate J. Type and number of Ki-ras point mutations related to stage of human colorectal cancer. Cancer Res 1994; 54: 3376-3378.
14. Finkelstein SD, Sayegh R, Christensen S, Swalsky PA. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer 1993; 71: 3827-3838.
15. Boughdady IS, Kinsella AR, Haboubi NY, Schofield PF. K-ras gene mutations in adenomas and carcinomas of the colon. Surg Onc 1992; 1: 275-282.
16. Going JJ, Lamb RF. Practical histological microdissection for PCR analysis. J Pathol 1996; 179: 121-124.
17. Lamb RF, Going JJ, Pickford I, Birnie GD. Allelic imbalance at NME1 in microdissected primary and metastatic human colorectal carcinoma is frequent but not associated with metastasis to lymph-nodes or liver. Cancer Res 1996; 56: 916-920.
18. Williams AC, Browne SJ, Yeudal W, et al. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma. Oncogene 1993; 8: 3063-3072.
19. Vries VM, Bogaard M, Elst H, Boom J, Eb A, Bos JL. A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. Gene 1986; 50: 313-320.
20. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall, 1991.
21. Bos JL, Fearon E, Hamilton S, et al. Prevalence of ras gene mutation in human colorectal cancer. Nature 1987; 327: 293-297.
22. Span M, Moerkerk PTM, Degoeij AFPM, Arends JW. A detailed analysis of K-ras point mutations in relation to tumour progression and survival in colorectal cancer patients. Int J Cancer 1996; 69: 241-245.
23. Urosevic N, Krtolica K, Skaro-Milic A, Knezevic-Usaj S, Dujic A. Prevalence to G-to-T transversions among K-ras oncogene mutations in human colorectal tumors in Yugoslavia. Int J Cancer 1993; 54: 249-254.
24. Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682-4689.
25. Kato M, Ito Y, Kobayashi S, Isono K. Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastasic recurrence. Cancer 1996; 77: 1729-1735.
26. Suchy B, Zietz C, Rabes HM. K-ras point mutations in human colorectal carcinomas: relation to aneuploidy and metastasis. Int J Cancer 1992; 52: 30-33.
27. Oudejans JJ, Slebos RJC, Zoetmulder FAN, Mooi WJ, Rodenhuis S. Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver. Int J Cancer 1991; 49: 875-879.
28. Moffett BF, Baban D, Bao L, et al. Fate of clonal lineages during neoplasia and metastasis studied with an incorporated genetic marker. Cancer Res 1992; 54: 1737-1743.
29. Kohl NE, Omer CA, Conner MW, et al. Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nature Med 1995; 1: 792-797.
30. Slebos RJC, Boerrigter L, Evers SG, Wisman P, Mooi JW, Rodenhuis S. A rapid and simple procedure for the routine detection of ras point mutations in formalin-fixed, paraffin-embedded tissues. Diagn Mol Pathol 1992; 1: 136-141.
31. Laurent-Puig P, Olschwang S, Delattre O, et al. Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 1992; 102: 1136-1141.
32. Kern SE, Fearson ER, Tersmette KWF, et al. Allelic loss in colorectal carcinoma. J Am Med Assoc 1989; 261: 3099-3103.
33. Benhattar J, Losi L, Chaubert P, Givel JC, Costa J. Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology 1993; 104: 1044-1048.
34. Andreyev HGN, Norman AR, Cunningham D, Oates J, Clarke PA. Kirsten ras mutations in 2,667 patients with colorectal cancer: results of the RASCAL (ras collaborative) project. Gut 1997; 40 (Suppl 1): A49.
35. Keohavong P, De Michele MAA, Melacrinos AC, Landreneau RJ, Weyant RJ, Siegfried JM. Detection of K-ras mutations in lung carcinomas: relationship to prognosis. Clin Cancer Res 1996; 2: 414-418.
36. Seeburg PH, Colby WW, Capon DJ, Goeddel DV, Levinson AD. Biological properties of human c-Ha-ras 1 genes mutated at codon 12. Nature 1984; 312: 71-75.
37. Marshall CJ. Ras effectors. Curr Opin Cell Biol 1996; 8: 197-204.
38. Goody RS, Pai EF, Schlichting I, et al. Studies on the structure and mechanism of H-ras p21. Philos Trans R Soc London Ser B 1992; 336: 3-10.
39. Li G, D'Souza-Schorey C, Barbieri MA, Cooper JA, Stahl PD. Uncoupling of membrane ruffling and pinocytosis during RAS signal transduction. J Biol Chem 1997; 272: 10337-10340.
40. Yamamoto H, Itoh F, Senota A, et al. Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells. J Clin Lab Anal 1995; 9: 297-301.
41. Rak J, Filmus J, Finkenzeller G, Grugal S, Mariné D, Kerbel RS. Oncogenes as inducers of tumor angiogenesis. Can Met Rev 1995; 14: 263-277.